 |
 Video: What is a Stock Split?
|
|
|
| Prime Medicine is a biotechnology company committed to delivering a class of differentiated one-time curative genetic therapies, Prime Editors, to address a spectrum of diseases by deploying Prime Editing technology. Co.'s in-licensed Prime Editing technology has the ability to repair mutations. Prime Editors have two main components that act together to edit deoxyribonucleic acid (DNA): a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme, and a pegRNA, that targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. According to our Prime Medicine stock split history records, Prime Medicine has had 0 splits. | |
|
Prime Medicine (PRME) has 0 splits in our Prime Medicine stock split history database.
Looking at the Prime Medicine stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Prime Medicine shares, starting with a $10,000 purchase of PRME, presented on a split-history-adjusted basis factoring in the complete Prime Medicine stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/20/2022 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$15.37 |
|
| End price/share: |
$5.59 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-63.63% |
|
| Average Annual Total Return: |
-48.21% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,637.47 |
|
| Years: |
1.54 |
|
|
|
|
|
